DUOS TECHNOLOGIES GROUP, INC. current report, 17 February 2022

Duos Technologies Group, Inc. - Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Duos Technologies Group, Inc. (DUOT) on February 22, 2022, covering events occurring on February 17, 2022. The filing details the completion of a public equity offering and the company's status regarding Nasdaq listing compliance.

Key Financial Metrics and Capital Structure

  • Capital Raised: The Company issued an additional 198,750 shares of Common Stock to cover over-allotments at an offering price of $4.00 per share.
  • Total Proceeds: Net proceeds from the entire offering (initial issuance plus over-allotment) were approximately $5.7 million before expenses.
  • Outstanding Shares: As of February 17, 2022, the total number of Common Stock shares issued and outstanding is 6,089,343.
  • Historical Equity: The filing references stockholders' equity of $865,221 as reported in the quarterly report for the period ended September 30, 2021.

Material Changes and Listing Status

The Company previously received notice from Nasdaq on November 23, 2021, indicating non-compliance with Marketplace Rule 5550(b)(1) due to stockholders' equity falling below the required $2,500,000 minimum. The capital raised through the February 2022 offering is intended to restore compliance with this stockholders' equity requirement. The filing states that as of the report date, the Company believes it has regained compliance, though Nasdaq will continue to monitor ongoing status.

Management Commentary and Use of Proceeds

Management intends to use the net proceeds from the offering for potential acquisitions, general corporate purposes, and working capital. The filing does not provide specific forward-looking guidance, revenue projections, or detailed risk factors beyond the contingent risk of delisting if compliance is not evidenced in the next periodic report.

Investor Verification Checklist

  • Verify the final net proceeds after deducting all offering expenses to confirm the exact capital injection.
  • Confirm the updated stockholders' equity balance in the next periodic report to ensure continued Nasdaq compliance.
  • Monitor for any announcements regarding specific acquisitions funded by the $5.7 million in proceeds.
  • Review the full underwriting agreement for details on lock-up periods or additional obligations to the underwriter.